LIFE SCIENCE TOOLS MARKET ANALYSIS

Life Science Tools Market, By Product (Consumables, Instruments, Services), By Technology (Genomics, Proteomics, Cell Biology, Stem Cell Research, Immunology), By Application (Drug Discovery and Development, Clinical Diagnostics, Genomic and Proteomic Research, Cell Biology Research, Others), By End User (Academic and Research Institutions, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Laboratories, Contract Research Organizations, Government and Regulatory Agencies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024
Code : CMI5357
Pages :190
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Life Science Tools Market Regional Insights

To learn more about this report, Request sample copy

North America remains the dominant region in the global life science tools market and is anticipated to hold 43.5% of the market share in 2024. The presence of major players and strong research infrastructure has propelled the market growth over the years. The region is a hub for the biotechnology and pharmaceutical industries with strong government funding for research activities. Several top universities in the U.S. are actively engaged in research collaborations with industry players, driving innovation. With large healthcare spends, the demand for advanced tools to accelerate drug discovery and development processes continues to rise in the region. Increasing investments by the market players is expected to foster the market growth over the forecast period. For instance, in June 2022, Illumina, Inc., a biotechnology company, announced its investment in Time Boost Capital, a USD 30 million genomics venture fund that offers start-ups that have completed the Illumina Accelerator Cambridge matching funding in order to make advancements in human health. Illumina, Inc. joined a select group of the U.S. and European investors in the life sciences fund, including cornerstone investor LifeArc.

Asia Pacific has emerged as the fastest growing regional market, led by countries such as China and India. Massive government investments to strengthen research capabilities and develop the local manufacturing sector have boosted the adoption of tools across various application areas. The rising spends on healthcare by these nations along with increasing disease prevalence rates is propelling market expansion. Prominent global players have set up manufacturing bases in the region to cater to the growing demand as well as benefit from lower production costs. This has made high-end tools more affordable and assessable for domestic customers. Meanwhile, export opportunities for Asian products continue to rise as the quality standards match international benchmarks. The pool of well-educated and English-speaking talent base further reinforces the growth trajectory of the market.